TY - JOUR T1 - Reduced dengue incidence following deployments of <em>Wolbachia</em>-infected <em>Aedes aegypti</em> in Yogyakarta, Indonesia: a quasi-experimental trial using controlled interrupted time series analysis JF - medRxiv DO - 10.1101/2020.03.15.20036566 SP - 2020.03.15.20036566 AU - Citra Indriani AU - Warsito Tantowijoyo AU - Edwige Rancès AU - Bekti Andari AU - Equatori Prabowo AU - Dedik Yusdi AU - Muhammad Ridwan Ansari AU - Dwi Satria Wardhana AU - Endah Supriyati AU - Indah Nurhayati AU - Inggrid Ernesia AU - Sigit Setyawan AU - Iva Fitriana AU - Eggi Arguni AU - Yudiria Amelia AU - Riris Andono Ahmad AU - Nicholas P. Jewell AU - Suzanne M. Dufault AU - Peter A. Ryan AU - Benjamin R. Green AU - Thomas F. McAdam AU - Scott L. O’Neill AU - Stephanie K. Tanamas AU - Cameron P. Simmons AU - Katherine L. Anders AU - Adi Utarini Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/03/20/2020.03.15.20036566.abstract N2 - Background Ae. aegypti mosquitoes stably transfected with the intracellular bacterium Wolbachia pipientis (wMel strain) have been deployed for the biocontrol of dengue and related arboviral diseases in multiple countries. Field releases in northern Australia have previously demonstrated near elimination of local dengue transmission from Wolbachia-treated communities, and pilot studies in Indonesia have demonstrated the feasibility and acceptability of the method. We conducted a quasi-experimental trial to evaluate the impact of scaled Wolbachia releases on dengue incidence in an endemic setting in Indonesia.Methods and findings In Yogyakarta City, Indonesia, following an extensive community engagement campaign, wMel Wolbachia-carrying mosquitoes were released every two weeks for 13–15 release rounds over seven months in 2016–17, in a contiguous 5 km2 area (population 65,000). A 3 km2 area (population 34,000) on the opposite side of the city was selected a priori as an untreated control area, on the basis of comparable socio-demographic characteristics and historical dengue incidence. Passive surveillance data on notified hospitalised dengue patients was used to evaluate the epidemiological impact of Wolbachia deployments, using controlled interrupted time series analysis. Rapid and sustained introgression of wMel Wolbachia into local Ae. aegypti populations was achieved. Thirty-four dengue cases were notified from the intervention area and 53 from the control area (incidence 26 vs 79 per 100,000 person-years) during the 24 months after Wolbachia was deployed. This corresponded in the regression model to a 73% reduction in dengue incidence (95% confidence interval 49%,86%) associated with the Wolbachia intervention. Exploratory analysis including an additional 6 months of post-intervention observations showed a small strengthening of this effect (30 vs 115 per 100,000 person-years; 76% reduction in incidence, 95%CI 60%,86%).Conclusions These findings demonstrate a significant reduction in dengue incidence following successful introgression of Wolbachia into local Ae. aegypti populations in an endemic setting in Indonesia. These results are consistent with previous field trials in northern Australia, and support the effectiveness of this novel approach for the control of dengue and other Aedes-borne diseases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Tahija Foundation, Indonesia. The funders had no role in study design, data collection, data analysis, data interpretation, or preparation of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe entomological datasets used during the current study are available from the authors on reasonable request. The dengue case notification data and NS1 rapid diagnostic test results are available from the Yogyakarta District Health Office and individual Yogyakarta puskesmas clinics, respectively, but restrictions apply to the availability of these data, which were used under license for the current study and are not publicly available. Data may be made available by the authors upon reasonable request, with permission of Yogyakarta District Health Office.AWED‘Applying Wolbachia to eliminate dengue’ (randomised controlled trial currently ongoing in Yogyakarta)BG trapBiogents Sentinel TrapCIconfidence intervalsCRCTcluster randomised controlled trialDENVdengue virusDFdengue feverDHFdengue haemorrhagic feverDHODistrict Health OfficeICD-10International Classification of Diseases, 10th revisionIRRIncidence rate ratioITSinterrupted time seriesMRCMosquito release containerNS1non-structural protein1 QAquality assuranceRDTrapid diagnostic testRT-PCRreverse transcription polymerase chain reactionWMPWorld Mosquito Program ER -